2,510 followers
New Research: Predicting clinical response to everolimus in ER+ breast cancers using machine-learning https://t.co/3mgGX3GxZe #MolBioSci
New Research: Predicting clinical response to everolimus in ER+ breast cancers using machine-learning https://t.co/3mgGX3GxZe #MolBioSci
Everolimus (mTOR inhibitor) can benefit patients with advanced ER+ breast cancer. Our latest predictive model uses cancer cell gene expression to predict clinical response to everolimus: https://t.co/zDhM52UE9m
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning https://t.co/cR604maJ59